Chances are, people will simply call Crick.
The leaders of the British Centre for Medical Research and Innovation (UKCMRI), a gigantic biomedical laboratory facility scheduled to open in central London in 2015, apparently heard the complaints about their heavy name and acronym. They just announced in July the plant will officially become the Francis Crick Institute to honor the Nobel British laureate who co-discovered the structure of DNA. The name change coincides with a new report which approves the scientific view of the installation, but also revives a debate on its location. Published by the House of Commons Science and Technology Committee, the report questions whether the benefits of the site from the city center, such as transport networks and access to universities and hospitals, were worth and limits location added.
The Panel concluded:
In our view the case for a central London location was not overwhelming and UKCMRI could be located elsewhere.
The construction of the Centre starts now and the decision can not be reversed, but it is essential that the UKCMRI develop plans and implement measures to ensure that those outside the South East part of the project and obtain maximum benefit.
The review of the UKCMRI comes as the project is about to start construction on the building that will house over 1,000 researchers and staff. Many of them are from the famous National Institute for Medical Research (NIMR) in Mills Hill, just outside of London, which will then be closed. It was the debate on whether to move NIMR in central London or to rejuvenate its facilities which, after much acrimony, eventually led to the unusual partnership that created UKCRMI. The Medical Research Council, the Wellcome Trust, CancerResearchUK and several London universities contribute all estimates land are now over $ 1 billion in the project now.
Beyond the question of the location, the MPs found little to complain about in their review of UKCRMI. They noted that the project has "experienced management team with a proven track" and the U.K. government had given promises that UKCRMI partners, not the British taxpayer, were responsible for cost overruns.
0 Komentar